ATAI Life Sciences N.V [NASDAQ: ATAI] traded at a high on Monday, posting a 3.73 gain after which it closed the day’ session at $1.67.
The results of the trading session contributed to over 7238213 shares changing hands. Over the past one week, the price volatility of ATAI Life Sciences N.V stands at 17.68% while the volatility over the past one month is 11.91%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for ATAI stock reached $329.32 million, with 166.03 million shares outstanding and 117.06 million shares in the current float. Compared to the average trading volume of 906.18K shares, ATAI reached a trading volume of 7238213 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about ATAI Life Sciences N.V [ATAI]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATAI shares is $7.80 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATAI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for ATAI Life Sciences N.V shares, keeping their opinion on the stock as Buy, with their previous recommendation back on Nov-19-24. The new note on the price target was released on April 03, 2024, representing the official price target for ATAI Life Sciences N.V stock. Previously, the target price had yet another raise to $18, while Loop Capital analysts kept a Buy rating on ATAI stock.
The Average True Range (ATR) for ATAI Life Sciences N.V is set at 0.16, with the Price to Sales ratio for ATAI stock in the period of the last 12 months amounting to 997.94. The Price to Book ratio for the last quarter was 1.92, with the Price to Cash per share for the same quarter was set at 0.51.
How has ATAI stock performed recently?
ATAI Life Sciences N.V [ATAI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.70. With this latest performance, ATAI shares gained by 30.47% in over the last four-week period, additionally sinking by -3.47% over the last 6 months – not to mention a rise of 50.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ATAI stock in for the last two-week period is set at 68.62, with the RSI for the last a single of trading hit 72.25, and the three-weeks RSI is set at 65.48 for ATAI Life Sciences N.V [ATAI]. The present Moving Average for the last 50 days of trading for this stock 1.2186, while it was recorded at 1.4920 for the last single week of trading, and 1.5582 for the last 200 days.
ATAI Life Sciences N.V [ATAI]: Deeper insight into the fundamentals
ATAI Life Sciences N.V’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.81 and a Current Ratio set at 5.81.
Earnings analysis for ATAI Life Sciences N.V [ATAI]
With the latest financial reports released by the company, ATAI Life Sciences N.V posted -0.12/share EPS, while the average EPS was predicted by analysts to be reported at -0.16/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.04. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ATAI.
Insider trade positions for ATAI Life Sciences N.V [ATAI]
There are presently around $26.84%, or 29.82%% of ATAI stock, in the hands of institutional investors. The top three institutional holders of ATAI stocks are: WALLEYE CAPITAL LLC with ownership of 2.76 million shares, which is approximately 1.7388%. MORGAN STANLEY, holding 2.72 million shares of the stock with an approximate value of $$3.62 million in ATAI stocks shares; and MORGAN STANLEY, currently with $$1.74 million in ATAI stock with ownership which is approximately 0.8225%.
